See every side of every news story

Published 3 days ago • loading... • Updated 3 days ago

GC Biopharma Submits IND Application for Phase 1 Clinical Trial of COVID-19 mRNA Vaccine in Korea

Summary by Charleston Gazette-Mail

YONGIN, South Korea, Sept. 22, 2025 /PRNewswire/ -- GC Biopharma (006280.KS), a leading South Korean pharmaceutical company, announced today that it has submitted an Investigational New Drug (IND) application to the Ministry of Food and Drug Safety (MFDS) in South…

68 Articles

68 Articles

Bennington Banner

PR Newswire

Charleston Gazette-Mail

Watauga Democrat

WBOC 16

Cecil Daily

Delaware Business Now

TBNweekly

The Herald-Dispatch

ashepostandtimes.com

Greeneville Publishing Company

The Courier Express

Brattleboro Reformer

Madison Courier

Record Argus - Serving Greenville, PA since 1848

The Berkshire Eagle

Islander News

The Progress

Rutland Herald

The Daily News

Tullahoma News

Kingsport Times-News

knoxvilledailysun.com

Queens Chronicle

williamsondailynews.com

The Logan Banner

Livingston County News

romesentinel.com

The AI Journal

Morgan County Citizen

coasttv.com

mainstreetnews.com

Independent-Messenger

Woonsocket Call

MyHorryNews.com

The Daily News - Jacksonville, NC

Williamson Herald

parispi.net

Hometown News Brevard

keenesentinel.com

The Clarion News

The Daily Press

kentuckytoday.com

Biltmore Beacon

The Miami Times

Saint Albans Messenger

The Caswell Messenger

Fairfax County Times

Oswego County News Now

newportvermontdailyexpress.com

Yadkin Ripple

Brunswicktimes Gazette

daily-tribune.com

Carroll News

Westminster Cable Network

thesussexsurrydispatch.com

Observer News Enterprise

Florida Courier

Courier Journal

miltonindependent.com

The Kane Republican

The Tomahawk

The Inquirer and Mirror

YourGV.com

The Courier-Tribune

delmarvasportsnetwork.com

Lincoln Times News

mountaineagle.com

+67 Reposted by 67 other sources

GC Biopharma Submits IND Application for Phase 1 Clinical Trial of COVID-19 mRNA Vaccine in Korea

YONGIN, South Korea, Sept. 22, 2025 /PRNewswire/ -- GC Biopharma (006280.KS), a leading South Korean pharmaceutical company, announced today that it has submitted an Investigational New Drug (IND) application to the Ministry of Food and Drug Safety (MFDS) in South…

3 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources68

Leaning Left9Leaning Right3Center21Last Updated2 days agoBias Distribution

64% Center

Bias Distribution

64% of the sources are Center

64% Center

+4

+16

Untracked bias

+26

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States 3 days ago on Tuesday, September 23, 2025.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics